What is Mayer Laboratories?
Mayer Laboratories distinguishes itself in the intimate wellness market through its comprehensive product portfolio, encompassing premium condoms, advanced lubricants, and sophisticated fertility tracking devices. Leveraging more than 35 years of industry experience, the company places a strong emphasis on meticulous scientific research, stringent quality control in manufacturing, and the utilization of superior ingredients. This dedication to enhancing intimate health and pleasure, coupled with a commitment to social responsibility and customer satisfaction, has enabled Mayer Laboratories to reach and serve millions of consumers globally. Their core mission revolves around fostering intimacy and connection through innovative, science-driven solutions.
How much funding has Mayer Laboratories raised?
Mayer Laboratories has raised a total of $42K across 1 funding round:
Debt
$42K
Debt (2021): $42K with participation from PPP
What's next for Mayer Laboratories?
The substantial expansion capital obtained by Mayer Laboratories, situated at a significant Series B/C stage, is poised to fuel strategic growth initiatives. This financing is expected to bolster the company's product development pipeline, enhance its manufacturing capabilities, and potentially expand its market reach into new territories or demographic segments. With a solid foundation built over decades, Mayer Laboratories is strategically positioned to capitalize on evolving consumer demands for sophisticated and science-backed intimate wellness solutions, aiming to further solidify its leadership in the global market.
See full Mayer Laboratories company page
